mesalamine and cyclin d1

mesalamine has been researched along with cyclin d1 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caruso, R; Fantini, MC; Fina, D; Macdonald, TT; Monteleone, G; Pallone, F; Palmieri, G; Pellegrini, R; Sarra, M; Stolfi, C1
Brand, L; Hüppe, D; Ladigan, S; Munding, J; Pox, CP; Reinacher-Schick, AC; Reiser, M; Schmiegel, W; Tannapfel, A; Ziebarth, W1
Ferguson, LR; Pichai, MV1

Reviews

1 review(s) available for mesalamine and cyclin d1

ArticleYear
Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.
    World journal of gastroenterology, 2012, Jun-21, Volume: 18, Issue:23

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Cyclin D1; Gene Silencing; Humans; Matrix Metalloproteinases; Mesalamine; Molecular Targeted Therapy; Nanotechnology; Tumor Necrosis Factor-alpha

2012

Other Studies

2 other study(ies) available for mesalamine and cyclin d1

ArticleYear
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine.
    Gastroenterology, 2010, Volume: 138, Issue:1

    Topics: Aminosalicylic Acids; Animals; Anticarcinogenic Agents; Azoxymethane; Benzamides; Carcinogens; Cell Death; Cell Division; Colitis; Colonic Neoplasms; Cyclin D1; Dextran Sulfate; eIF-2 Kinase; Endoplasmic Reticulum; Flow Cytometry; G1 Phase; Gene Silencing; HCT116 Cells; Humans; Mesalamine; Mice; Resting Phase, Cell Cycle; Xenograft Model Antitumor Assays

2010
The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the β-catenin signaling pathway.
    Carcinogenesis, 2012, Volume: 33, Issue:3

    Topics: Adenoma; beta Catenin; Cadherins; Cell Line, Tumor; Colitis, Ulcerative; Colorectal Neoplasms; Cyclin D1; Cyclooxygenase 2; Disease Progression; Epithelial Cells; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Male; Mesalamine; Ornithine Decarboxylase; Signal Transduction; TCF Transcription Factors; Tumor Suppressor Protein p53; Wnt Proteins; Wnt Signaling Pathway

2012